Valley National Advisers’s ResMed RMD Stock Holding History

Valley National Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Sell	7,495 -73	-1%	-$15.1K	0.16%	114
2026 Q1	$1.7M	Buy	7,568 +93	+1%	+$23.2K	0.22%	95
2025 Q4	$1.8M	Sell	7,475 -180	-2%	-$46K	0.25%	99
2025 Q3	$2.09M	Buy	7,655 +184	+2%	+$50.3K	0.32%	79
2025 Q2	$1.93M	Buy	7,471 +7	+0.1%	+$1.67K	0.31%	83
2025 Q1	$1.67M	Buy	7,464 +185	+3%	+$43.2K	0.3%	87
2024 Q4	$1.66M	Buy	7,279 +181	+3%	+$43.6K	0.3%	89
2024 Q3	$1.73M	Buy	7,098 +7,043	+12,805%	+$1.57M	0.31%	94
2024 Q2	$10K	Buy	55 +1	+2%	+$203	﹤0.01%	625
2024 Q1	$10K	Sell	54 -4	-7%	-$733	﹤0.01%	645
2023 Q4	$9K	Buy	58 +36	+164%	+$5.53K	﹤0.01%	686
2023 Q3	$3K	Buy	+22	New	+$3.98K	﹤0.01%	779

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Valley National Advisers's RMD Position: Q2 2026 in Review

Valley National Advisers reduced its ResMed (RMD) stake by 0.96% in Q2 2026, selling an estimated $15.1K and leaving 7,495 shares worth $1.46M. The position accounts for 0.16% of the portfolio, ranked #114.

Valley National Advisers first reported a position in RMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.09M in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Valley National Advisers held 7,495 shares of ResMed worth $1.46M as of Q2 2026.
Valley National Advisers sold 73 ResMed shares in Q2 2026, an estimated $15.1K.
ResMed made up 0.16% of Valley National Advisers's portfolio in Q2 2026, its #114 holding.
Valley National Advisers first reported a position in ResMed in Q3 2023 and has held it in 12 quarters since.
Valley National Advisers's ResMed position peaked at $2.09M in Q3 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.